迈瑞医疗收盘上涨2.82%，滚动市盈率25.62倍，总市值2852.87亿元

Group 1 - The core viewpoint of the news is that Mindray Medical's stock has seen a recent increase, but its price-to-earnings (PE) ratio is significantly lower than the industry average, indicating potential undervaluation [1][2] - As of June 5, Mindray Medical's closing price was 235.3 yuan, with a PE ratio of 25.62, which is the lowest in 43 days, and a total market capitalization of 285.29 billion yuan [1] - The average PE ratio for the medical device industry is 50.97, with a median of 36.67, placing Mindray Medical at the 55th position in the industry ranking [1][2] Group 2 - On June 5, there was a net inflow of 12.42 million yuan in main funds for Mindray Medical, with a total inflow of 7.79 million yuan over the past five days [1] - The latest quarterly report for Q1 2025 shows that Mindray Medical achieved a revenue of 8.24 billion yuan, a year-on-year decrease of 12.12%, and a net profit of 2.63 billion yuan, down 16.81% year-on-year, with a gross profit margin of 62.53% [1]